Inderal Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

inderal

astrazeneca limited - propranolol hydrochloride 160mg - film coated tablet - 160 mg - active: propranolol hydrochloride 160mg excipient: calcium carbonate carmellose calcium cochineal gelatin glycerol hypromellose magnesium stearate titanium dioxide

ULCIDINE TABLET Kanada - angličtina - Health Canada

ulcidine tablet

valeant canada lp / valeant canada s.e.c. - famotidine - tablet - 40mg - famotidine 40mg - histamine h2-antagonists

ERGOTAMINE TARTRATE AND CAFFEINE tablet, film coated Spojené štáty - angličtina - NLM (National Library of Medicine)

ergotamine tartrate and caffeine tablet, film coated

cintex services, llc - ergotamine tartrate (unii: mru5xh3b48) (ergotamine - unii:pr834q503t), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - ergotamine tartrate 1 mg - ergotamine tartrate and caffeine tablets are indicated as therapy to abort or prevent vascular headache; e.g., migraine, migraine variants or so-called “histaminic cephalalgia.” coadministration of ergotamine with potent cyp 3a4 inhibitors (ritonavir, nelfinavir, indinavir, erythromycin, clarithromycin, and troleandomycin) has been associated with acute ergot toxicity (ergotism) characterized by vasospasm and ischemia of the extremities (see precautions: drug interactions ), with some cases resulting in amputation. there have been rare reports of cerebral ischemia in patients on protease inhibitor therapy when ergotamine tartrate and caffeine tablets was coadministered, at least one resulting in death. because of the increased risk of ergotism and other serious vasospastic adverse events, ergotamine use is contraindicated with these drugs and other potent inhibitors of cyp 3a4 (e.g., ketoconazole, itraconazole) (see warnings: cyp 3a4 inhibitors ). ergotamine tartrate and caffeine tablets may cau

ERGOTAMINE TARTRATE AND CAFFEINE tablet, film coated Spojené štáty - angličtina - NLM (National Library of Medicine)

ergotamine tartrate and caffeine tablet, film coated

mikart, llc - ergotamine tartrate (unii: mru5xh3b48) (ergotamine - unii:pr834q503t), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - ergotamine tartrate 1 mg - ergotamine tartrate and caffeine tablets are indicated as therapy to abort or prevent vascular headache; e.g., migraine, migraine variants or so-called “histaminic cephalalgia.” coadministration of ergotamine with potent cyp 3a4 inhibitors (ritonavir, nelfinavir, indinavir, erythromycin, clarithromycin, and troleandomycin) has been associated with acute ergot toxicity (ergotism) characterized by vasospasm and ischemia of the extremities (see precautions: drug interactions ), with some cases resulting in amputation. there have been rare reports of cerebral ischemia in patients on protease inhibitor therapy when ergotamine tartrate and caffeine tablets was coadministered, at least one resulting in death. because of the increased risk of ergotism and other serious vasospastic adverse events, ergotamine use is contraindicated with these drugs and other potent inhibitors of cyp 3a4 (e.g., ketoconazole, itraconazole) (see warnings: cyp 3a4 inhibitors ). er